Sign In
Buy LIFE
$16.89
-0.375 (-2.17%)
At Close: Jun 03, 2026
Here's a roundup of top developments in the biotech space over the last 24 hours:
Scaling The Peaks
(Biotech stocks that hit 52-week highs March 12.)
Masimo...
aTyr Pharma Announces Exercise and Closing of Over-Allotment Option in Public Offering
12:30pm, Tuesday, 10'th Mar 2020
SAN DIEGO, March 10, 2020 (GLOBE NEWSWIRE) -- aTyr Pharma, Inc. (LIFE), a biotherapeutics company engaged in the discovery and development of innovative medicines based on novel immunological pathwa
Financial Survey: Fate Therapeutics (NASDAQ:FATE) versus aTyr Pharma (NASDAQ:LIFE)
05:06am, Tuesday, 10'th Mar 2020
Fate Therapeutics (NASDAQ:FATE) and aTyr Pharma (NASDAQ:LIFE) are both medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their profitabilit
FDA OKs new use of Boehringer Ingelheim's Ofev
07:20pm, Monday, 09'th Mar 2020
Under Priority Review and Breakthrough Therapy status, the FDA approves privately held Boehringer Ingelheim's Ofev (nintedanib) oral capsules for the treatment of patients with chronic fibrosing (scar
Contrasting aTyr Pharma (NASDAQ:LIFE) and Rubius Therapeutics (NASDAQ:RUBY)
06:10am, Saturday, 07'th Mar 2020
aTyr Pharma (NASDAQ:LIFE) and Rubius Therapeutics (NASDAQ:RUBY) are both small-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their
aTyr Pharma Announces Poster Presentation at the American Association for Cancer Research (AACR) Annual Meeting
01:00pm, Tuesday, 03'rd Mar 2020
SAN DIEGO, March 03, 2020 (GLOBE NEWSWIRE) -- aTyr Pharma, Inc. (LIFE), a biotherapeutics company engaged in the discovery and development of innovative medicines based on novel immunological pathwa
aTyr Pharma Announces Publication in the Journal Cellular and Molecular Immunology
01:00pm, Thursday, 27'th Feb 2020
SAN DIEGO, Feb. 27, 2020 (GLOBE NEWSWIRE) -- aTyr Pharma, Inc. (LIFE), a biotherapeutics company engaged in the discovery and development of innovative medicines based on novel immunological pathway
Andreas Halvorsen Plunges Into aTyr Pharma
11:11pm, Tuesday, 11'th Feb 2020
Viking Global leader releases real-time trade in interstitial lung disease therapy provider Continue reading...
aTyr Pharma Announces Pricing of $18 million Underwritten Public Offering
02:00pm, Thursday, 06'th Feb 2020
SAN DIEGO, Feb. 06, 2020 (GLOBE NEWSWIRE) -- aTyr Pharma, Inc. (LIFE), a biotherapeutics company engaged in the discovery and development of innovative medicines based on novel immunological pathway
Andreas Halvorsen Trims Adaptive Biotechnologies Stake
04:27pm, Monday, 03'rd Feb 2020
The immune-driven biotech company went public last June Continue reading...
